MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,138K
Free Cash flow
-$4,303K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds, net of issuance costs,...
Deconsolidation of subsidiary
Stock-based compensation
Others
Negative Cash Flow Breakdown
Accounts payable, accrued and ot...
Net loss
Effect of exchange rate changes ...
Payment of preferred stock divid...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Stock-based compensation
1,673
Net loss
-1,399
Prepaid expenses and other assets
-1,544
Changes in lease liability
10
Accounts payable, accrued and other current liabilities
-11,079
Depreciation
1
Deconsolidation of subsidiary
4,947
Net cash used in operating activities
-4,303
Purchase of property, plant and equipment
0
Net cash used in investing activities
0
Proceeds, net of issuance costs, from issuing common stock and pre-funded warrants, net
5,567
Payment of preferred stock dividend
41
Proceeds from the exercise of stock options and warrants, net of issuance costs
0
Net cash provided by (used) in financing activities
5,526
Effect of exchange rate changes on cash and cash equivalents
-85
Net increase (decrease) in cash and cash equivalents
1,138
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds, net of issuance
costs, from issuing...
$5,567K
Net cash provided by
(used) in financing...
$5,526K
Canceled cashflow
$41K
Net increase
(decrease) in cash and cash...
$1,138K
Canceled cashflow
$4,388K
Payment of preferred
stock dividend
$41K
Deconsolidation of subsidiary
$4,947K
Stock-based compensation
$1,673K
Prepaid expenses and
other assets
-$1,544K
Changes in lease
liability
$10K
Depreciation
$1K
Net cash used in
operating activities
-$4,303K
Effect of exchange rate
changes on cash and cash...
-$85K
Canceled cashflow
$8,175K
Accounts payable,
accrued and other...
-$11,079K
Net loss
-$1,399K
Buy us a coffee
Cyclacel Pharmaceuticals, Inc. (CYCC)
Cyclacel Pharmaceuticals, Inc. (CYCC)